Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Gene Synthesis Market to 2025 - Global Analysis and Forecasts By Products & Services (Services, Consumable, Software), Application (Research & Development Activities, Diagnostics, Therapeutics, Others) End Users (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, Others) and Geography

  • THE3206833
  • 150 Pages
  • August 2018
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The gene synthesis market is estimated to account for US$ 20,122.3 Mn by the end of 2025, escalating at a CAGR of 28.7% during the forecast period from 2018 to 2025, rising from US$ 2,866.1 Mn in 2017. The rising numbers of start-up companies and increase in investments & funds for gene synthesis are the few factors that are expected to fuel the growth of global gene synthesis market. However, the lack of skilled professionals and long approval processes can be the restraint for the market in the forecast period. On the other hand, the increasing usage of gene synthesis in personalized medicine act like trend for the global gene synthesis market.

In the gene synthesis market, the services segment is expected to the fastest growing segment in the forecast period, by product & services. The services under gene synthesis such as DNA isolation, library preparation, sequencing, data analysis and biological interpretation of the results in a proper and easily read format. Various companies offer the services such as, Novogene provides the broad range of gene synthesis services for the wide range of sample types. Moreover, Eurofins Genomics is the first service provider in Europe that provides gene synthesis services with the help of Roche/454 GS20.

The academic & research institutes segment held the largest share of the gene synthesis market, by end user. The academic & research institutes are getting funds from the various organizations for betterment of gene synthesis. Additionally, many of the organizations have formed due to the partnerships between various organizations and universities for research in the transformation of scientific technologies to make the life-saving treatments for patients. For instance, TrinSeq, the Trinity Genome Sequencing Laboratory, present in Trinity Translational Medicine Institute (TTMI), Trinity College Dublin. Trinity Genome Sequencing Laboratory has an Illumina MiSeq, the gene synthesis platform for performing the ultra-high throughput genomics solutions.

The gene synthesis market was estimated through extensive primary and secondary sources that included a vast array of government authorized websites such as World Health Organization (WHO), National Institutes of Health (NIH), Research & Development (R&D), United Nations (UN), National Institute of Health (NIH) and others. The primary respondents included chair-holders and representatives of the demand and supply side for healthcare industries as well as medical professionals at various biopharmaceutical companies and research centers.

TABLE OF CONTENTS

1. INTRODUCTION 20

1.1 SCOPE OF THE STUDY 20

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 20

2. GLOBAL GENE SYNTHESIS MARKET - KEY TAKEAWAYS 21

3. GLOBAL GENE SYNTHESIS MARKET - MARKET LANDSCAPE 24

3.1 OVERVIEW 24

3.2 MARKET SEGMENTATION 24

3.2.1 Global Gene Synthesis Market - By Products & Services 25

3.2.2 Global Gene Synthesis Market - By Application 25

3.2.3 Global Gene Synthesis Market - By End User 26

3.2.4 Global Gene Synthesis Market - By Geography 26

3.3 PEST ANALYSIS 27

3.3.1 North America - PEST Analysis 27

3.3.2 Europe- PEST Analysis 29

3.3.3 Asia Pacific - PEST Analysis 31

3.3.4 Middle East And Africa- PEST Analysis 33

3.3.5 South and Central America - PEST Analysis 35

4. GLOBAL GENE SYNTHESIS MARKET - KEY MARKET DYNAMICS 37

4.1 KEY MARKET DRIVERS 37

4.1.1 Increase in Investments & Funds for Gene Synthesis 37

4.1.2 Rising Numbers of Start-up Companies 38

4.1.3 Technological Advancements 39

4.2 KEY MARKET RESTRAINTS 40

4.2.1 Lack of Skilled Professionals 40

4.2.2 Long Approval Processes 40

4.3 KEY MARKET OPPORTUNITIES 41

4.3.1 Emerging Nations 41

4.4 FUTURE TRENDS 42

4.4.1 Usage of Gene Synthesis in Personalized Medicine 42

4.5 IMPACT ANALYSIS 43

5. GENE SYNTHESIS MARKET - GLOBAL ANALYSIS 44

5.1 GLOBAL GENE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS 44

5.2 GLOBAL GENE SYNTHESIS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 45

5.3 MARKET POSITIONING 46

5.4 PERFORMANCE OF KEY PLAYERS 46

5.4.1 Eurofins Scientific 46

5.4.2 GenScript 46

5.4.3 Thermo Fisher Scientific Inc. 46

5.5 EXPERT OPINIONS 47

6. GENE SYNTHESIS MARKET ANALYSIS- BY PRODUCTS & SERVICES 48

6.1 OVERVIEW 48

6.2 GLOBAL GENE SYNTHESIS MARKET SHARE, BY PRODUCTS & SERVICES, 2017 & 2025 (%) 48

6.3 CONSUMABLES 49

6.3.1 Overview 49

6.3.2 Global Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 50

6.4 SOFTWARE 50

6.4.1 Overview 50

6.4.2 Global Software Market Revenue and Forecasts to 2025 (US$ Mn) 51

6.5 SERVICES MARKET 51

6.5.1 Overview 51

6.5.2 Global Services Market Revenue and Forecasts to 2025 (US$ Mn) 52

7. GLOBAL GENE SYNTHESIS MARKET ANALYSIS- BY APPLICATION 53

7.1 OVERVIEW 53

7.2 GLOBAL GENE SYNTHESIS MARKET SHARE, BY APPLICATION, 2017 & 2025 (%) 53

7.3 DIAGNOSTICS 54

7.3.1 Overview 54

7.3.2 Global Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn) 54

7.4 THERAPEUTICS 55

7.4.1 Overview 55

7.4.2 Global Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 55

7.5 RESEARCH & DEVELOPMENTAL ACTIVITIES 56

7.5.1 Overview 56

7.5.2 Global Research & Developmental Activities Market Revenue and Forecasts to 2025 (US$ Mn) 56

7.6 OTHER APPLICATIONS 57

7.6.1 Overview 57

7.6.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 57

8. GLOBAL GENE SYNTHESIS MARKET ANALYSIS - BY END USER 58

8.1 OVERVIEW 58

8.2 GLOBAL GENE SYNTHESIS MARKET SHARE, BY END USER, 2017 & 2025 (%) 58

8.3 ACADEMIC & RESEARCH INSTITUTES MARKET 59

8.3.1 Overview 59

8.3.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 59

8.4 DIAGNOSTIC LABORATORIES MARKET 60

8.4.1 Overview 60

8.4.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2025 (US$ Mn) 60

8.5 BIOTECH & PHARMACEUTICAL COMPANIES MARKET 61

8.5.1 Overview 61

8.5.2 Global Biotech & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn) 61

8.6 OTHERS MARKET 62

8.6.1 Overview 62

8.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 62

9. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 63

9.1 OVERVIEW 63

9.2 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64

9.3 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 64

9.4 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 65

9.5 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 65

9.6 NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 66

9.7 US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67

9.7.1 US Gene synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 68

9.7.2 US Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 68

9.7.3 US Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 69

9.7.4 US Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 69

9.8 CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70

9.8.1 Canada Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 70

9.8.2 Canada Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 71

9.8.3 Canada Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 71

9.8.4 Canada Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 71

9.9 MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72

9.9.1 Mexico Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 72

9.9.2 Mexico Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 73

9.9.3 Mexico Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 73

9.9.4 Mexico Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 73

10. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 74

10.1 OVERVIEW 74

10.2 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75

10.3 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 75

10.4 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76

10.5 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 76

10.6 EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77

10.7 UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78

10.7.1 UK Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 79

10.7.2 UK Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 79

10.7.3 UK Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 80

10.7.4 UK Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 80

10.8 GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81

10.8.1 Germany Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 81

10.8.2 Germany Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 82

10.8.3 Germany Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 82

10.8.4 Germany Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 82

10.9 FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83

10.9.1 France Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 83

10.9.2 France Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 84

10.9.3 France Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84

10.9.4 France Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 84

11. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 85

11.1 OVERVIEW 85

11.2 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86

11.3 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 86

11.4 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 87

11.5 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 87

11.6 ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88

11.7 CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89

11.7.1 China Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 89

11.7.2 China Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 90

11.7.3 China Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 90

11.7.4 China Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 90

11.8 JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91

11.8.1 Japan Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 91

11.8.2 Japan Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 92

11.8.3 Japan Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 92

11.8.4 Japan Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 92

11.9 INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93

11.9.1 India Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 93

11.9.2 India Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 94

11.9.3 India Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 94

11.9.4 India Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94

12. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 95

12.1 OVERVIEW 95

12.2 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96

12.3 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 96

12.4 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97

12.5 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97

12.6 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 98

12.7 UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99

12.8 UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99

12.8.1 UAE Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 100

12.8.2 UAE Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 100

12.8.3 UAE Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 100

12.9 SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

12.10 SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

12.10.1 Saudi Arabia Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 102

12.10.2 Saudi Arabia Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 102

12.10.3 Saudi Arabia Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 102

12.11 SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103

12.12 SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103

12.12.1 South Africa Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 104

12.12.2 South Africa Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104

12.12.3 South Africa Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104

13. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 105

13.1 OVERVIEW 105

13.2 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106

13.3 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 106

13.4 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107

13.5 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107

13.6 SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 108

13.7 BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109

13.7.1 Brazil Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 109

13.7.2 Brazil Gene Synthesis Market Revenue And Forecasts to 2025, By Product & Services (US$ Mn) 110

13.7.3 Brazil Gene Synthesis Market Revenue And Forecasts to 2025, By Application (US$ Mn) 110

13.7.4 Brazil Gene Synthesis Market Revenue And Forecasts to 2025, By End User (US$ Mn) 110

14. GENE SYNTHESIS MARKET -INDUSTRY LANDSCAPE 111

14.1 OVERVIEW 111

14.2 GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 111

14.3 ORGANIC GROWTH STRATEGIES 111

14.3.1 Overview 111

14.3.2 Product Launch 112

14.3.3 Expansion 113

14.3.4 Approvals 113

14.4 INORGANIC GROWTH STRATEGIES 114

14.4.1 Overview 114

14.4.2 Agreements 114

14.4.3 Acquisitions 115

14.4.4 Partnerships & Collaborations 116

14.4.5 Other Inorganic Strategies 117

15. GENE SYNTHESIS MARKET -KEY COMPANY PROFILES 118

15.1 THERMO FISHER SCIENTIFIC INC. 118

15.1.1 Key Facts 118

15.1.2 Business Description 118

15.1.3 Financial Overview 119

15.1.4 Product Portfolio 119

15.1.5 SWOT Analysis 120

15.1.6 Key Developments 120

15.2 INTEGRATED DNA TECHNOLOGIES, INC. 121

15.2.1 Key Facts 121

15.2.2 Business Description 121

15.2.3 Financial Overview 121

15.2.4 Product Portfolio 121

15.2.5 SWOT Analysis 122

15.2.6 Key Developments 122

15.3 TWIST BIOSCIENCE 123

15.3.1 Key Facts 123

15.3.2 Business Description 123

15.3.3 Financial Overview 123

15.3.4 Product portfolio 123

15.3.5 SWOT ANALYSIS 124

15.3.6 KEY DEVELOPMENTS 124

15.4 ORIGENE TECHNOLOGIES, INC. 126

15.4.1 Key Facts 126

15.4.2 Business Description 126

15.4.3 Financial Overview 126

15.4.4 Product Portfolio 126

15.4.5 SWOT Analysis 127

15.4.6 Key Developments 127

15.5 BIOCAT GMBH 128

15.5.1 Key Facts 128

15.5.2 Business Description 128

15.5.3 Financial Overview 129

15.5.4 Product Portfolio 129

15.5.5 SWOT Analysis 129

15.5.6 Key Developments 129

15.6 GENSCRIPT 130

15.6.1 Key Facts 130

15.6.2 Business Description 130

15.6.3 Financial Overview 131

15.6.4 Product Portfolio 131

15.6.5 SWOT Analysis 132

15.6.6 Key Developments 132

15.7 EUROFINS SCIENTIFIC 133

15.7.1 Key Facts 133

15.7.2 Business Description 133

15.7.3 Financial Overview 133

15.7.4 Product/ Services Portfolio 134

15.7.5 SWOT Analysis 134

15.7.6 Key Developments 134

15.8 BIONEER CORPORATION 136

15.8.1 Key Facts 136

15.8.2 Business Description 136

15.8.3 Financial Overview 136

15.8.4 Product/ Services Portfolio 137

15.8.5 SWOT Analysis 137

15.8.6 Key Developments 138

15.9 ATUM 139

15.9.1 Key Facts 139

15.9.2 Business Description 139

15.9.3 Financial Overview 140

15.9.4 Product Portfolio 140

15.9.5 SWOT Analysis 140

15.9.6 Key Developments 140

15.10 GENEWIZ 141

15.10.1 Key Facts 141

15.10.2 Business Description 141

15.10.3 Financial Overview 142

15.10.4 Service Portfolio 142

15.10.5 SWOT Analysis 142

15.10.6 Key Developments 143

16. APPENDIX 144

16.1 ABOUT THE INSIGHT PARTNERS 144

16.2 GLOSSARY OF TERMS 145

16.3 METHODOLOGY 147

16.3.1 Coverage 148

16.3.2 Secondary Research 149

16.3.3 Primary Research 149

LIST OF TABLES

TABLE 1. VENTURE CAPITAL FIRMS INVESTING IN SOME COUNTRIES FOR BIOTECHNOLOGY 37

TABLE 2. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 64

TABLE 3. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 65

TABLE 4. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 65

TABLE 5. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 68

TABLE 6. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69

TABLE 7. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69

TABLE 8. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 71

TABLE 9. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 71

TABLE 10. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 71

TABLE 11. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 73

TABLE 12. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73

TABLE 13. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 73

TABLE 14. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 75

TABLE 15. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76

TABLE 16. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 76

TABLE 17. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 79

TABLE 18. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 80

TABLE 19. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 80

TABLE 20. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 82

TABLE 21. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82

TABLE 22. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 82

TABLE 23. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 84

TABLE 24. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84

TABLE 25. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 84

TABLE 26. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 86

TABLE 27. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 87

TABLE 28. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 87

TABLE 29. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 90

TABLE 30. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90

TABLE 31. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 90

TABLE 32. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 92

TABLE 33. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92

TABLE 34. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 92

TABLE 35. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 94

TABLE 36. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 94

TABLE 37. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94

TABLE 38. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 96

TABLE 39. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97

TABLE 40. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97

TABLE 41. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 98

TABLE 42. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 100

TABLE 43. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100

TABLE 44. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 100

TABLE 45. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 102

TABLE 46. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 102

TABLE 47. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 102

TABLE 48. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 104

TABLE 49. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104

TABLE 50. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104

TABLE 51. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 106

TABLE 52. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107

TABLE 53. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107

TABLE 54. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICES (US$ MN) 110

TABLE 55. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 110

TABLE 56. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 110

TABLE 57. RECENT PRODUCT LAUNCH IN GENE SYNTHESIS MARKET 112

TABLE 58. RECENT EXPANSION IN GENE SYNTHESIS MARKET 113

TABLE 59. RECENT APPROVALS IN GENE SYNTHESIS MARKET 113

TABLE 60. RECENT AGREEMENTS IN GENE SYNTHESIS MARKET 114

TABLE 61. RECENT ACQUISITIONS IN GENE SYNTHESIS MARKET 115

TABLE 62. RECENT PARTNERSHIPS & COLLABORATIONS IN GENE SYNTHESIS MARKET 116

TABLE 63. RECENT OTHER INORGANIC STRATEGIES IN GENE SYNTHESIS MARKET 117

TABLE 64. GLOSSARY OF TERMS, GENE SYNTHESIS MARKET 145

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC GENE SYNTHESIS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 21

FIGURE 2. GLOBAL GENE SYNTHESIS MARKET BY PRODUCTS & SERVICES, MARKET SHARE (%), 2017 22

FIGURE 3. GLOBAL GENE SYNTHESIS MARKET BY APPLICATION, MARKET SHARE (%), 2017 22

FIGURE 4. GLOBAL GENE SYNTHESIS MARKET BY END USER, MARKET SHARE (%), 2017 23

FIGURE 5. GENE SYNTHESIS MARKET SEGMENTATION 24

FIGURE 6. GENE SYNTHESIS SEGMENTATION, BY REGION 25

FIGURE 7. NORTH AMERICA PEST ANALYSIS 27

FIGURE 8. EUROPE PEST ANALYSIS 29

FIGURE 9. ASIA PACIFIC PEST ANALYSIS 31

FIGURE 10. MIDDLE EAST AND AFRICA PEST ANALYSIS 33

FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 35

FIGURE 12. GENE SYNTHESIS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 43

FIGURE 13. GLOBAL GENE SYNTHESIS MARKET - REVENUE FORECASTS AND ANALYSIS - 2016- 2025 44

FIGURE 14. GLOBAL GENE SYNTHESIS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 45

FIGURE 15. GLOBAL GENE SYNTHESIS MARKET, BY PRODUCTS & SERVICES, 2017 & 2025 (%) 48

FIGURE 16. GLOBAL CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50

FIGURE 17. GLOBAL SOFTWARE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51

FIGURE 18. GLOBAL SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52

FIGURE 19. GLOBAL GENE SYNTHESIS MARKET SHARE, BY APPLICATION 2017 & 2025 (%) 53

FIGURE 20. GLOBAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54

FIGURE 21. GLOBAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55

FIGURE 22. GLOBAL RESEARCH & DEVELOPMENTAL ACTIVITIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56

FIGURE 23. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57

FIGURE 24. GLOBAL GENE SYNTHESIS MARKET SHARE, BY END USER, 2017 & 2025 (%) 58

FIGURE 25. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59

FIGURE 26. GLOBAL DIAGNOSTIC LABORATORIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60

FIGURE 27. GLOBAL BIOTECH & PHARMACEUTICAL COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61

FIGURE 28. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62

FIGURE 29. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 63

FIGURE 30. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64

FIGURE 31. NORTH AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 66

FIGURE 32. US GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68

FIGURE 33. CANADA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70

FIGURE 34. MEXICO GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72

FIGURE 35. EUROPE GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 74

FIGURE 36. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75

FIGURE 37. EUROPE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 77

FIGURE 38. UK GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79

FIGURE 39. GERMANY GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81

FIGURE 40. FRANCE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83

FIGURE 41. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 85

FIGURE 42. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86

FIGURE 43. ASIA PACIFIC GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88

FIGURE 44. CHINA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89

FIGURE 45. JAPAN GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91

FIGURE 46. INDIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93

FIGURE 47. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95

FIGURE 48. MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96

FIGURE 49. UAE GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99

FIGURE 50. SAUDI ARABIA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101

FIGURE 51. SOUTH AFRICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103

FIGURE 52. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 105

FIGURE 53. SOUTH AND CENTRAL AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106

FIGURE 54. SOUTH AND CENTRAL AMERICA GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 108

FIGURE 55. BRAZIL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109

FIGURE 56. GROWTH STRATEGIES IN GENE SYNTHESISMARKET, 2016-2018 111

FIGURE 57. ORGANIC GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 112

FIGURE 58. INORGANIC GROWTH STRATEGIES IN GENE SYNTHESIS MARKET, 2016-2018 114

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750